These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9931648)

  • 21. [p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent].
    Würl P; Taubert H; Meye A; Berger D; Holzhausen HJ; Schmidt H; Hinze R; Rath FW; Schönfelder M
    Verh Dtsch Ges Pathol; 1998; 82():358-61. PubMed ID: 10095460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group.
    Mertens F; Strömberg U; Mandahl N; Dal Cin P; De Wever I; Fletcher CD; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van Den Berghe H; Vanni R; Willén H
    Cancer Res; 2002 Jul; 62(14):3980-4. PubMed ID: 12124330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
    Kudawara I; Matsumine A; Ohzono K
    J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
    Kuhnen C; Herter P; Müller O; Muehlberger T; Krause L; Homann H; Steinau HU; Müller KM
    Mod Pathol; 2000 Sep; 13(9):1005-13. PubMed ID: 11007041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A spatially and temporally restricted mouse model of soft tissue sarcoma.
    Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
    Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
    Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D
    Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer genetics.
    Knudson AG
    Am J Med Genet; 2002 Jul; 111(1):96-102. PubMed ID: 12124744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].
    Yamaguchi U; Hasegawa T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1340-5. PubMed ID: 15446553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment.
    Hogendoorn PC; Collin F; Daugaard S; Dei Tos AP; Fisher C; Schneider U; Sciot R;
    Eur J Cancer; 2004 Jul; 40(11):1644-54. PubMed ID: 15251152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent progress in the genomics of soft tissue sarcomas.
    Conley AP; Trent J; Zhang W
    Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular profiling in the diagnosis and treatment of high grade sarcomas.
    Antonescu CR
    Ultrastruct Pathol; 2008; 32(2):37-42. PubMed ID: 18446666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Frequency, distribution and prognostic relevance of p53 mutations in soft tissue sarcomas].
    Taubert H; Würl P; Meye A; Bache M; Kroll J; Lautenschläger C; Thamm B; Holzhausen HJ; Hinze R; Schmidt H; Berger D; Rath FW
    Verh Dtsch Ges Pathol; 1998; 82():340-4. PubMed ID: 10095457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial sarcoma: challenging pedigrees.
    Lynch HT; Deters CA; Hogg D; Lynch JF; Kinarsky Y; Gatalica Z
    Cancer; 2003 Nov; 98(9):1947-57. PubMed ID: 14584079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Soft tissue sarcomas: the role of histology and molecular pathology for differential diagnosis].
    Poremba C
    Verh Dtsch Ges Pathol; 2006; 90():59-72. PubMed ID: 17867581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
    Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
    Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the kiel pediatric tumor registry].
    Harms D
    Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):268-74. PubMed ID: 15503256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TP53 in bone and soft tissue sarcomas.
    Thoenen E; Curl A; Iwakuma T
    Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.